1.
Borne P von dem, Beaumont F, Starrenburg C, Oudshoorn M, Hale G, Falkenburg J, Fibbe W, Willemze R, Barge R. Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab. Haematologica [Internet]. 2006Nov.1 [cited 2026Nov.8];91(11):1559-62. Available from: https://haematologica.org/article/view/4219